|
|
| MRD / Regn No. |
: 280 |
Date |
: 18/06/2026 |
| Patient Name |
: Sumita Polley |
Age & Gender |
: 57 Yrs. / Female |
| Contact No. |
: 9163090046 |
UHID |
: |
| Ht / Wt / BMI |
: 157 / 75 / 30.43 |
BP S / BP D |
: 127 / 72 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DIABETES (15/Sep/2006) | DYSLIPIDEMIA (15/Sep/2022) | HYPOTHYROIDISM (15/Sep/2022) | |
| Salient Investigations |
: |
CREATININE: 0.71 | EGFR EGLOMERULAR FILTRATION RATE: 90.81 mL/min/1.73m2 | HBA1C GLYCOSYLATED HEMOGLOBIN: 7.5 % | MICROALBUMIN CREATININE RATIO: 87.8 mcg/mg | TSH THYROID STIMULATING HORMONE: 1.71 mIU/L | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
THYROXINE 75 MCG
THYRONORM 75 MCG
Medicine For HYPOTHYROIDISM |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
| MUST BE TAKEN ON AN EMPTY STOMACH. COFFEE TEA OR BREAKFAST MUST BE TAKEN ONLY AFTER 30 MINUTES. OTHER DRUGS CAN INTERFERE WITH THE ABSORPTION OF THYROXINE | |
|
2 |
INJECTION GLARGINE (INJ U100)
LANTUS
Medicine For GLUCOSE CONTROL |
SQ |
0-0-12 |
BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
3 |
ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG + 100 MG SITAGLIPTIN + METFORMIN 1000 MG
GLUXIT TRIO SR |
PO |
1-0-0 |
BEFORE BREAKFAST
|
|
|
|
4 |
ANTIHYPERGLYCEMIC REPAGLINIDE 1 MG + VOGLIBOSE 0.3 MG
EUREPA V |
PO |
1-1-0 |
BEFORE BREAKFAST AND LUNCH
|
TILL NEXT VISIT |
|
|
5 |
ATORVASTATIN 20 MG
ATOCOR 20 |
PO |
0-0-1 |
BEFORE DINNER
|
TILL NEXT VISIT |
|
|
6 |
TELMISARTAN 20 MG
TELSAR |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 18/Dec/2026 |
| Tests Suggested For Next Visit |
: SMBG,HBA1C-HPLC METHOD,RETINA CHECK UP,UACR:SPOT SAMPLE |
| |
|
| |
|
